-- The London Proteomics Discussion Group --
Proteomics seminar series for the South East
We are a free, local proteomics seminar series in the South East,
with a focus towards networking, discussion and supporting early career researchers.
The LPDG...
was founded to bring together the large community of proteomics scientists all working in and around London. We aim to provide a space for discussion, with a focus on methods and early career researchers (two fundamental building blocks of good research!), on all topics related to proteomics. The meetings comprise of research talks framed by a proteomics methods challenge, lunch, refreshments and pizza - they are free to attend thanks to sponsorship.
Meeting Dates:
Happy to be here on Bluesky. We'll be doing a little series of "meet the committee members" over the next few weeks, having just held our elections for new members. Look out for the old and new faces coming soon 😊
— London Proteomics Discussion Group (@lpdg.bsky.social) December 8, 2024 at 7:00 PM
These seminars would not be possible without our amazing sponsors.
If you are interested in sponsoring an LPDG seminar,
please get in touch at sponsor@londonproteomics.co.uk
for 20th February 2025 Time 12:00
Would you like to present at an LPDG meeting? Email: speaker@londonproteomics.co.uk
Research presentations from:
Dr Kustatscher is a group leader and MRC Career Development Fellow at the Centre for Cell Biology in Edinburgh. The aim of our lab is to understand, from a systems biology perspective, how cells regulate protein levels and how these processes are disrupted in cancer cells. We address this question by combining proteomics and computational approaches, including machine-learning.
I am a final year PhD student in the Mardakheh lab at BCI, QMUL/University of Oxford. My research focuses on understanding nucleolar changes important for driving the hyperactivation of ribosome biogenesis in cancer
Dr Zhang joined Rothamsted Research in Harpenden 2013. He has been studying N degron pathway of targeted protein degradation in plants. He has established LC-MS proteomics platform in Rothamsted with a Vanquish neo and Eclipse Orbitap. His recent study has found BIG enhances Arg/N-degron pathway-mediated protein degradation to regulate Arabidopsis hypoxia responses and suberin deposition.
Dr Nishimura is a Postdoctoral Research Associate in Muscle Proteomics. His research focuses on the molecular and cellular mechanisms regulating skeletal muscle protein turnover and mass in both health and disease, with key contributions in the areas of skeletal muscle aging and facioscapulohumeral muscular dystrophy (FSHD) through proteomics-based approaches
Dr. David Britton is the Director of Global Proteomics Limited, a company focused on proteomics recruitment, training, and research. He has over 20 years of experience in LC-MS/MS-based proteomics and cancer research across both academia and industry, including co-founding Kinomica Limited, where he served as Chief Scientific Officer. At GPL, Dave is pioneering a candidate-centric approach to proteomics recruitment, connecting top talent with employers through innovative, pre-vetted profiles.Â